# LASRY MARC

> Institutional holdings reported to the SEC as of Q3 2025 on Form 13F. CIK 1259927. Source: https://holderbook.com/funds/1259927-lasry-marc/

- Reported value: $15.1M
- Positions: 9
- Weight of the ten largest: 100.0%
- Filed: 2025-11-14

A 13F reports long US equity positions only. Short positions, bonds, foreign listings, private holdings and cash are not visible, so this is not the manager's whole book.

## Holdings

| Security | Ticker | Value | Shares | Weight | Quarters held |
|---|---|---|---|---|---|
| XBP EUROPE HOLDINGS INC | [XBP](https://holderbook.com/stocks/XBP/) | $9.8M | 12,107,907 | 64.9% | 1 |
| HYPERION DEFI INC | [HYPD](https://holderbook.com/stocks/HYPD/) | $2.3M | 240,124 | 15.3% | 1 |
| NEXTDECADE CORP | [NEXT](https://holderbook.com/stocks/NEXT/) | $1.7M | 254,270 | 11.5% | 9 |
| DARIOHEALTH CORP | [DRIO](https://holderbook.com/stocks/DRIO/) | $403.3K | 23,246 | 2.7% | 4 |
| VALION BIO INC | [VBIO](https://holderbook.com/stocks/VBIO/) | $293.7K | 101,638 | 2.0% | 1 |
| FORGE GLOBAL HOLDINGS INC | [FRGE](https://holderbook.com/stocks/FRGE/) | $192.0K | 11,363 | 1.3% | 2 |
| BEYOND AIR INC | [XAIR](https://holderbook.com/stocks/XAIR/) | $189.3K | 81,950 | 1.3% | 5 |
| ORCHESTRA BIOMED HLDGS INC | [OBIO](https://holderbook.com/stocks/OBIO/) | $151.0K | 60,869 | 1.0% | 10 |
| RANI THERAPEUTICS HLDGS INC | [RANI](https://holderbook.com/stocks/RANI/) | $31.4K | 62,887 | 0.2% | 15 |

## What the disclosed book did

Not the fund's return. This is the change in value of the positions disclosed on Form 13F, had they been left untouched, against SPY over the same quarter ends.

| Quarter | Book | Market | Difference | Priced |
|---|---|---|---|---|
| Q4 2024 | +46.7% | +2.1% | +44.5% | 70% |
| Q3 2024 | -21.1% | +5.4% | -26.5% | 98% |
| Q2 2024 | +12.5% | +4.0% | +8.4% | 90% |
| Q1 2024 | +8.5% | +10.0% | -1.5% | 100% |
| Q4 2023 | +4.1% | +11.2% | -7.1% | 95% |
| Q3 2023 | +1.0% | -3.6% | +4.5% | 98% |
| Q2 2023 | -0.7% | +8.3% | -9.0% | 97% |
| Q1 2023 | -17.4% | +7.0% | -24.5% | 95% |

## Quarter by quarter

| Quarter | Value | Positions |
|---|---|---|
| Q3 2025 | $15.1M | 9 |
| Q2 2025 | $17.9M | 8 |
| Q1 2025 | $21.8M | 10 |
| Q4 2024 | $22.5M | 11 |
| Q3 2024 | $55.0M | 10 |
| Q2 2024 | $101.2M | 11 |
| Q1 2024 | $117.5M | 11 |
| Q4 2023 | $67.7M | 10 |
| Q3 2023 | $101.4M | 13 |
| Q2 2023 | $77.3M | 12 |
| Q1 2023 | $52.1M | 10 |
| Q4 2022 | $64.4M | 11 |